Abstract
Rheumatic fever is a multisystem inflammatory disease that occurs as a delayed sequelae to group A streptococcal pharyngitis. The important clinical manifestations are migratory polyarthritis, carditis, chorea, subcutaneous nodules and erythema marginatum occurring in varying combinations. The pathogenesis of this disorder remains elusive: an antigenic mimicry hypothesis best explains the affliction of various organ systems after a lag period following pharyngeal infection. In its classic milder form, the disorder is largely self-limited and resolves without sequelae, but carditis may be fatal in severe forms of the disease. Chronic and progressive damage to the heart valves leads to the most important public health manifestations of the disease. Anti-inflammatory agents provide dramatic clinical improvement, but do not prevent the subsequent development of rheumatic heart disease. The role of corticosteroids in treatment of carditis is uncertain and controlled studies have failed to demonstrate improved long term prognosis. Chorea, once considered a benign self-limited disease, is now felt to require more aggressive treatment, in particular with sedatives. Prevention of first and subsequent attacks of rheumatic fever is the mainstay in the limited arsenal available to alter the natural history of this disease.
Similar content being viewed by others
References
Kaplan MH. Immunologic relationship of streptococcal and tissue antigens: properties of an antigen in certain strains of group A streptococci exhibiting an immunologic crossreaction with human heart tissue. J Immunol 1963; 90: 595–606
Siecel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pédiatrie population: factors related to the attack of rheumatic fever. N Engl J Med 1961; 265: 559–65
Weidebach W, Goldberg AC, Chiarella JM, et al. HLA class II antigens in rheumatic fever: analysis of the DR locus by restriction fragment-length polymorphism and oligotyping. Hum Immunol 1994; 40: 253–8
Yoshinoya S, Pope RM. Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5. J Clin Invest 1980; 65: 136–45
Disciascio G, Taranta A. Rheumatic fever in children. Am Heart J 1980; 99: 635–58
Pattarroyo ME, Winchester RJ, Vejerano A, et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979; 278: 173–4
Williams RC, Raizada V, Prakash K, et al. Studies of streptococcal membrane antigen-binding cells in acute rheumatic fever. J Lab Clin Med 1985; 105: 531–6
Pope RM. Rheumatic fever in the 1980s. Bull Rheum Dis 1989; 38: 1–8
Rose AG. Etiology of acquired valvular heart disease in adults: a survey of 18,132 autopsies and 100 consecutive valve replacement operations. Arch Pathol Lab Med 1986; 110: 385–8
Gordis L. The virtual disappearance of rheumatic fever in the United States. Circulation 1985; 72: 1155–62
World Health Organization. Community control of rheumatic heart disease in developing countries: a major public health problem. WHO Chronicle 1980; 34(9): 336–46
Rheumatic fever and rheumatic heart disease. Report of the World health Organization study group. WHO Tech Rep Ser 1988; 764: 1–62
Agarwal BL. Rheumatic heart disease unabated in developing countries. Lancet 1981; 2(8252): 910–1
Veasy LG, Wiedmeir SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain areas of the United States. N Engl J Med 1987; 316: 421–7
Hosier DM, Craenen JM, Teske DW, et al. Resurgence of acute rheumatic fever. Am J Dis Child 1987; 141: 730–3
Congeni B, Riggo C, Congeni J, et al. Outbreak of acute rheumatic fever in north-east Ohio. J Pediatr 1987; 111: 176–9
Wald ER, Dashefsky B, Feidt C, et al. Acute rheumatic fever in western Pennsylvania and the tri-state area. Pediatrics 1987; 80: 371–4
Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325: 783–93
Wald ER. Acute rheumatic fever. Curr Probl Pediatr 1993; 23: 264–70
Holmer C, Shulman ST. Clinical aspects of acute rheumatic fever. J Rheumatol 1991; 18 Suppl.: 2–13
Stollerman GH. The nature of rheumatogenic streptococci. Mt Sinai J Med 1996; 653: 144–57
Jones TD. Diagnosis of rheumatic fever. JAMA 1944; 126: 481–4
Kiss MHB. Articular involvement in rheumatic fever. Rev Soc Cardiol Estado de Sao Paulo 1993; 3: 26–31
Taranta A. Rheumatic fever: clinical aspects. In: Hollander JL, editor. Arthritis and allied conditions. 7th ed. Philadelphia (PA): Lea & Febiger, 1966: 694
Barnert AL, Terry EE, Persellin RN. Acute rheumatic fever in adults. JAMA 1975; 232: 925–8
Carmo HF, Vilela RG, Alvarenga SL, et al. Rheumatic fever in Goiania, Brazil. Rev Bras Reumatol 1994; 34: 61–4
da Silva NA, Pereira BA. Acute rheumatic fever: still a challenge. Rheum Dis Clin North Am 1997; 23: 545–68
Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update [correction. Published erratum appears in JAMA 1993; 269: 476]. JAMA 1992; 268: 2069–73
Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, Updated 1992. Circulation 1993; 87: 302–7
Amigo MC, Martinez-Lavin M, Reyes PA. Acute rheumatic fever. Rheum Dis Clin North Am 1993; 19: 333–50
Morales E, Pineda C, Martinez-Lavin M. Takayasu’s arteritis in children. J Rheumatol 1991; 18: 1081–4
Denny FW. T Duckett Jones and rheumatic fever in 1986. Circulation 1987; 76: 963–70
Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention for rheumatic fever: a statement for health professionals. Pediatrics 1995; 96: 758–64
Bisno AL. Rheumatic fever. In: Kelly WN, Harris Jr ED, Ruddy S, et al., editors. Textbook of rheumatology. 4th ed. Philadelphia (PA): W.B. Saunders, 1993: 1209
Pinals RS. Polyarthritis and fever. N Engl J Med 1994; 330: 769–74
Denny FW. A 45-year perspective on the streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clin Infect Dis 1994; 19: 1110–22
Chan AW, Webb G, Vellend H, et al. Delayed diagnosis of acute rheumatic fever in adults: a forgotten cause of febrile polyarthritis. J Rheumatol 1996; 23: 1999–2001
Vasan RS, Shrivastava S, Vijayakumar MD, et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996; 94: 73–82
Wilson NJ, Neutze JM. Editorial: echocardiographic diagnosis subclinical carditis in acute rheumatic fever. Int J Cardiol 1995; 50: 1–6
Gibofsky A, Zabriskie JB. Rheumatic fever: etiology, diagnosis, and treatment. In: Koopman WJ, editors. Arthritis and allied conditions. 13th ed. Baltimore (MD): Williams & Wilkins, 1997: 1581–94
Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of United States. J Pediatr 1994; 124(1): 9–16
Stollerman GH. Rheumatic fever. Lancet 1997; 349: 935–42
Bisno AL. Rheumatic fever. In: Kelly WN, Harris Jr ED, Ruddy S, et al., editors. Textbook of rheumatology. 5th ed. Philadelphia (PA): W.B. Saunders, 1997: 1225–40
Tompkins DG, Boxerbaum B, Liebman J. Long term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972; 45: 543–51
Thomas GT. Five year follow-up on patients with rheumatic fever treated by bed rest, steroids or salicylates. BMJ 1961; 1: 1635–9
Loeffler AM, Neches WH, Ortenzo M, et al. Identification of cases of acute rheumatic fever managed on an outpatient basis. Pediatr Infect Dis J 1995; 14: 975–8
Taranta A, Markowitz M. Rheumatic fever. 2nd ed. London: Kluwer Academic Publishing, 1989
Vaisman S, Guash J, Vignau A, et al. The failure of penicillin to alter acute rheumatic vasculitis. JAMA 1965; 194(12): 1284–6
Mortimer EA, Vaisman S, Vigneau A, et al. The effect of penicillin on acute rheumatic fever and valvular heart disease. N Engl J Med 1959; 260: 101–12
Gibofsky A, McCarty M, Veasy G, et al. ‘A rose by any other name…’ [editorial]. J Rheumatol 1995; 22: 379–81
Azevedo ECL. Febre reumatica. In: Oliveira SKF, Azevedo ECL, editors. Reumatologia pediatrica. Rio De Janeiro: Medsi, 1991: 139–51
Feinstein AR, Spagnuolo M, Gill FA. Rebound phenomenon in acute rheumatic fever. I. Incidence and significance. Yale J Biol Med 1961; 33: 259–78
Spagnuolo M, Feinstein AR. Rebound phenomenon in acute rheumatic fever. II. Treatment and prevention. Yale J Biol Med 1961; 33: 279–98
Combined rheumatic fever study group. A comparison of short-term intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. N Engl J Med 1965; 272: 63–70
Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: areview and meta-analysis. Medicine 1995; 74: 1–12
United Kingdom and United States Joint Report on Rheumatic Heart Disease: the natural history of rheumatic fever and rheumatic heart disease: ten-year report of a cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 1965; 32: 457-76
Czoniczer G, Amezcua F, Pelargonio S, et al. Therapy of severe rheumatic carditis: comparison of adrenocortical steroids and aspirin. Circulation 1964; 29: 813–9
Stollerman GH. Rheumatic fever. Arch Intern Med 1956; 98: 211–20
Timmis HH, Hardy JD, Watson DG, et al. Mitral valve replacement in a child during active rheumatic carditis: successful management of sixteen episodes of ventricular fibrillation. Ann Surg 1966; 164: 1034–40
Aron AM, Freeman JM, Carter S, et al. The natural history of Sydenham’s chorea. Am J Med 1965; 38: 83–95
Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham’s chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993; 91: 706–13
Mivakava M, Ohkubo O, Fuchigami T, et al. Effectiveness of haloperidol in the treatment of chorea minor. Brain Dev 1995; 27: 191–6
Ben Hamida M, Hamza F. Sydenham’s chorea in Tunisia: a report of 65 cases. Ann Med Intern 1979; 130: 359–64
Swedo SE. Sydenham’s chorea: a model for childhood autoimmune neuropsychiatric disorders. JAMA 1994; 272: 1788–91
Stollerman GH, Lewis AJ, Schulyz I, et al. Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med 1956; 20(2): 163–9
Taranta A, Klienberg E, Feinstein AR, et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. Relation of the rheumatic fever recurrence rate per streptococcal infection to pre-existing clinical features of the patients. Ann Intern Med 1964; 60 Suppl. 5: 58–67
Cumming RR. Acute rheumatic fever. Can Med Assoc J 1974; 111: 818–21
Spagnuolo M, Kloth H, Taranta A, et al. Natural history of rheumatic aortic regurgitation. Criteria predictive of death, congestive heart failure, and angina in young patients. Circulation 1971; 44: 368–80
Reyes VP, Raju S, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994; 331: 961–7
Turi ZG, Reyes VP, Raju S, et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. Circulation 1991; 83: 1179–85
Davis J, Schmidt WC. Benzathine penicillin G: its effectiveness in prevention of streptococcal infections in a heavily exposed population. N Engl J Med 1957; 256(8): 339–42
Haffejee I. Rheumatic fever and rheumatic heart disease: the current status of its immunology, diagnostic criteria, and prophylaxis. Q J Med 1992; 305: 641–58
Ayoub EM. Resurgence of rheumatic fever in the United States: the changing picture of a preventable illness. Postgrad Med 1992; 92: 133–6
Scaglione F, Demartini G, Arcidiacono MM, et al. Optimum treatment of streptococcal pharyngitis. Drugs 1997; 53: 86–97
Clinsburg CM, McCracken GH. A controlled comparative study of penicillin V and cefadroxyl therapy of group A streptococcal tonsillopharyngitis. J Int Med Res 1980; 8: 82–6
Stillerman M. Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatr Infect Dis J 1986; 5: 649–54
Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis 1978; 137 Suppl.: S74–S79
Levine BB. Antigenicity and cross-reactivity of penicillins and cephalosporins. J Infect Dis 1973; 128: S364–S366
Saxon A, Hassner A, Swabb EA, et al. Lack of cross-reactivity between aztreonam, a monobactum antibiotic, and penicillin in penicillin allergic subjects. J Infect Dis 1984; 149: 16–22
Tanz RR, Poncher JR, Corydon KE, et al. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 8: 119–23
Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96: 758–64
Lue HC, Wu MH, Wang JK, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr 1994; 125(5): 812–6
Padmavati S, Gupta V, Prakash, et al. Penicillin for rheumatic fever prophylaxis 3-weekly or 4-weekly schedule? J Assoc Physicians India 1987; 35(11); 753–5
Kaplan EL, Berrios S, Speth J, et al. Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1,200,000 units. J Pediatr 1989; 115(1): 146–50
Saxena S, Grover A, Singh M, et al. Efficacy of 4-weekly penicillin secondary prophylaxis in acute rheumatic fever/rheumatic heart disease (ARF/RHD). Indian Heart J 1996; 48: 490
International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991; 337: 1308–10
Sprunt K, Redman W, Leidy G. Penicillin resistant alpha streptococci in the pharynx of patients given oral penicillin. Pediatrics 1968; 42(6): 957–68
Stollerman GH. Rheumatic fever and streptococcal infection. New York: Grune & Stratton, 1975
Berrios X, del Campo E, Guzman B, et al. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: aprospective study. Ann Intern Med 1993; 118(6): 401–6
Majeed HA, Khuffash FA, Bhatnagar S, et al. Acute rheumatic polyarthritis: the duration of secondary prophylaxis. Am J Dis Child 1990; 144(7): 831–3
Lancefield RC. Current knowledge of the type specific M antigens of group A streptococci. J Immunol 1962; 89: 307–13
Beachy EH, Stollerman GH, Johnson RH, et al. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med 1979; 150: 862–77
Dale JB, Chiang EY, Lederer JW. Recombinant tetravalent group A streptococcal vaccine. J Immunol 1993; 151: 2188–94
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thatai, D., Turi, Z.G. Current Guidelines for the Treatment of Patients with Rheumatic Fever. Drugs 57, 545–555 (1999). https://doi.org/10.2165/00003495-199957040-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199957040-00007